Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex H Chang

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 18, 2007
The genetic engineering of hematopoietic stem cells: the rise of lentiviral vectors, the conundrum of the ltr, and the promise of lineage-restricted vectorsAlex H Chang, Michel Sadelain
Nature Biotechnology|July 18, 2006
Stem cell-derived erythroid cells mediate long-term systemic protein deliveryAlex H Chang, Matthias T Stephan, Michel Sadelain
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2008
Erythroid-specific human factor IX delivery from in vivo selected hematopoietic stem cells following nonmyeloablative conditioning in hemophilia B miceAlex H Chang, Matthias T Stephan, Leszek Lisowski, et al.
Frontiers in Oncology|October 10, 2022
Case report: Plasma cell leukemia secondary to multiple myeloma successfully treated with anti-BCMA CAR-T cell therapyJingjing Deng, Yuehui Lin, Defeng Zhao, et al.
Science China. Life Sciences|April 6, 2025
Integrating genomic features for prognosis in Chinese patients with B-cell lymphoma following chimeric antigen receptor T-cell therapyLinghui Zhou, Youqin Feng, Ruimin Hong, et al.
Frontiers in Medicine|October 27, 2022
Natural killer cell infusion for cytomegalovirus infection in pediatric patients with Wiskott-Aldrich syndrome following cord blood transplantation: A case report and literature reviewYongwei Yue, Lijun Meng, Jing Ling, et al.
Nature Medicine|November 21, 2007
T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejectionMatthias T Stephan, Vladimir Ponomarev, Renier J Brentjens, et al.
Frontiers in Medicine|November 21, 2022
Administration of granulocyte-macrophage colony-stimulating factor enhanced chimeric antigen receptor T-cell expansion and cellular immunity recovery without inducing cytokine release syndromeYing Jiang, Dan Feng, Chun Wang, et al.
Cytotherapy|July 22, 2023
A distinct cytokine network distinguishes chimeric antigen receptor T cell (CAR-T)-associated hemophagocytic lymphohistiocytosis-like toxicity (carHLH) from severe cytokine release syndrome following CAR-T therapyCheng Zu, Shenghao Wu, Mingming Zhang, et al.
Translational Oncology|November 14, 2017
Chimeric Antigen Receptor-Modified T Cells Redirected to EphA2 for the Immunotherapy of Non-Small Cell Lung CancerNing Li, Shaohui Liu, Mingjiao Sun, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 18, 2007
The genetic engineering of hematopoietic stem cells: the rise of lentiviral vectors, the conundrum of the ltr, and the promise of lineage-restricted vectorsAlex H Chang, Michel Sadelain
Nature Biotechnology|July 18, 2006
Stem cell-derived erythroid cells mediate long-term systemic protein deliveryAlex H Chang, Matthias T Stephan, Michel Sadelain
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2008
Erythroid-specific human factor IX delivery from in vivo selected hematopoietic stem cells following nonmyeloablative conditioning in hemophilia B miceAlex H Chang, Matthias T Stephan, Leszek Lisowski, et al.
Frontiers in Oncology|October 10, 2022
Case report: Plasma cell leukemia secondary to multiple myeloma successfully treated with anti-BCMA CAR-T cell therapyJingjing Deng, Yuehui Lin, Defeng Zhao, et al.
Science China. Life Sciences|April 6, 2025
Integrating genomic features for prognosis in Chinese patients with B-cell lymphoma following chimeric antigen receptor T-cell therapyLinghui Zhou, Youqin Feng, Ruimin Hong, et al.
Frontiers in Medicine|October 27, 2022
Natural killer cell infusion for cytomegalovirus infection in pediatric patients with Wiskott-Aldrich syndrome following cord blood transplantation: A case report and literature reviewYongwei Yue, Lijun Meng, Jing Ling, et al.
Nature Medicine|November 21, 2007
T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejectionMatthias T Stephan, Vladimir Ponomarev, Renier J Brentjens, et al.
Frontiers in Medicine|November 21, 2022
Administration of granulocyte-macrophage colony-stimulating factor enhanced chimeric antigen receptor T-cell expansion and cellular immunity recovery without inducing cytokine release syndromeYing Jiang, Dan Feng, Chun Wang, et al.
Cytotherapy|July 22, 2023
A distinct cytokine network distinguishes chimeric antigen receptor T cell (CAR-T)-associated hemophagocytic lymphohistiocytosis-like toxicity (carHLH) from severe cytokine release syndrome following CAR-T therapyCheng Zu, Shenghao Wu, Mingming Zhang, et al.
Translational Oncology|November 14, 2017
Chimeric Antigen Receptor-Modified T Cells Redirected to EphA2 for the Immunotherapy of Non-Small Cell Lung CancerNing Li, Shaohui Liu, Mingjiao Sun, et al.
Pageof 8